학술논문

Mammaprint and Blueprint are prognostic of outcome following neoadjuvant chemotherapy
Document Type
Journal
Source
CANCER RESEARCH; FEB 15 2022, 82 4, 3p. Supplement: S
Subject
Language
English
ISSN
15387445